SMTL ID : 2uzu.1

PKA structures of indazole-pyridine series of AKT inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-mer

Ligands

1 x L20: (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE(Non-covalent)

L20.1: 16 residues within 4Å: Chain A: T.37, F.40, G.41, R.42, V.43, A.56, K.58, L.60, M.106, E.107, Y.108, V.109, L.159, T.169, D.170, F.313 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.40, A:V.43, A:A.56, A:L.60, A:T.169, A:F.313 Hydrogen bonds: A:E.107, A:V.109 pi-Cation interactions: A:K.58

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhu, G.D. et al., Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension. J.Med.Chem. (2007)

Release Date

2007-06-05

Peptides

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT: A
CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
I

CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT

CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA

Related Entries With Identical Sequence